Korro Bio, Inc.

NASDAQ:KRRO

Biotechnology

Healthcare
$12.32 +15.88%

+$1.76 today

Market cap
$169.10M
Beta
2.10
P/E (TTM)
-1.3
EPS (TTM)
-$9.79
52W Low $5.20High $55.89

Volume 0.16M

Average 0.15M

Income Statement

Follow revenue through to earnings.

Revenue

$6.39M

FY 2025 · Annual

+181.5% YoY

Operating Income

-$87.34M

FY 2025 · Annual

Net Income

-$117.26M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue14.07M002.27M6.39M
Cost of Revenue3.84M0004.28M
Gross Profit10.23M002.27M2.11M
Gross Margin72.7%——100.0%33.0%
Research & Development59.32M42.2M57.25M63.64M65.58M
Selling, General & Admin34.93M16.8M36.54M30.55M28.16M
Operating Expenses94.26M59M84.53M94.18M89.45M
Depreciation & Amortization3.84M2.51M3.63M3.57M4.28M
EBITDA(80.07M)(56.49M)(80.9M)(88.35M)(83.06M)
EBITDA Margin-569.1%——-3890.1%-1299.5%
Operating Income(84.03M)(59M)(84.53M)(91.91M)(87.34M)
Operating Margin-597.3%——-4047.1%-1366.4%
Interest Income397K947K000
Interest Expense764K118K000
Other Income / Expenses(640K)976K3.39M8.47M(29.28M)
Income Before Tax(84.67M)(58.02M)(81.15M)(83.44M)(116.62M)
Pre-Tax Margin-601.9%——-3674.2%-1824.5%
Income Tax Expense15K10K27K141K637K
Net Income(84.69M)(58.03M)(81.17M)(83.58M)(117.26M)
Net Margin-602.0%——-3680.4%-1834.5%
EPS (Basic)(4.94)(227.58)(53.09)(9.37)(12.48)
EPS (Diluted)(4.94)(227.42)(53.08)(9.37)(12.48)
Weighted Avg Shares4.45M255K1.53M8.92M9.4M
Weighted Avg Shares (Diluted)4.45M255.17K1.53M8.92M9.4M

KRRO Earnings Waterfall · TTM

NASDAQ:KRRO · Revenue to Net Income

Key Ratios

EPS$-11.68
Gross Margin62.4%
Net Margin-1823.8%
P/E Ratio-2.4
P/S Ratio137.8

Analysis

$3.8M of revenue converted into -$113.5M of net income for the selected period. Gross margin is 62.4% and net margin is -1823.8%, showing how much revenue survives after costs and taxes. EPS is $-11.68, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 13, 2026
SC 13GSC 13G filingNov 12, 2026
10-QQuarterly reportNov 5, 2026
8-KCurrent reportNov 5, 2026
SC 13G/ASC 13G/A filingOct 27, 2026

How much revenue does KRRO generate?

Korro Bio, Inc. (KRRO) reported $6.39M of revenue in fiscal 2025.

Is KRRO profitable?

Korro Bio, Inc. (KRRO) reported -$117.26M of net income, with a net margin of -1834.5%.